No records
|
113 |
55758911100 |
Prasenohadi |
dr. Prasenohadi, Sp.P., Ph.D |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
In-hospital mortality of pulmonary tuberculosis with acute respiratory failure and related clinical risk factors |
Elhidsi M., Rasmin M., Prasenohadi |
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
|
Q3 |
|
|
153 |
6507688750 |
Elisna Syahruddin |
dr. Elisna Syahruddin, Ph.D., Sp.P(K) |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Cost-effectiveness analysis of tyrosine kinase inhibitors (erlotinib vs. gefitinib vs. afatinib) in non-small-cell lung cancer |
Nurhayati F., Anggriani Y., Syahruddin E., Ramadaniati H.U., Kusumaeni T. |
Journal of Applied Pharmaceutical Science |
|
Q2 |
|
|
340 |
8716259500 |
Sita L. Andarini |
dr. Sita L. Andarini, Sp.P, Ph.D. |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Hyperinflammation syndrome in covid-19 disease: Pathogenesis and potential immunomodulatory agents [Covid-19 hastalığında hiperenflamasyon sendromu: Patogenez ve potansiyel immünomodülatuvar ajanlar] |
Hidayat M., Handayani D., Nurwidya F., Andarini S.L. |
Turkish Journal of Immunology |
|
Q4 |
|
|
468 |
8716259500 |
Sita L. Andarini |
dr. Sita L. Andarini, Sp.P, Ph.D. |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Diagnostic predictors of active tuberculosis infection in diabetic patients with latent tuberculosis: A review on cathelicidin and 1,25-dihydroxyvitamin d3 |
Arliny Y., Yunus F., Burhan E., Andarini S., Jusman S.W.A., Yunir E., Kekalih A., Soeroton A.Y., Nurwidya F. |
Journal of Natural Science, Biology and Medicine |
|
Q3 |
|
|
113 |
15754578700 |
Menaldi Rasmin |
Prof. dr. H. Menaldi Rasmin, Sp.P(K), FCCP |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
In-hospital mortality of pulmonary tuberculosis with acute respiratory failure and related clinical risk factors |
Elhidsi M., Rasmin M., Prasenohadi |
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
|
Q3 |
|
|
349 |
36058523500 |
Triya Damayanti |
dr. Triya Damayanti, Sp.P., Ph.D. |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial |
Dilogo I.H., Aditianingsih D., Sugiarto A., Burhan E., Damayanti T., Sitompul P.A., Mariana N., Antarianto R.D., Liem I.K., Kispa T., Mujadid F., Novialdi N., Luviah E., Kurniawati T., Lubis A.M.T., Rahmatika D. |
Stem Cells Translational Medicine |
|
Q1 |
|
|
147 |
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Performance of ldbio aspergillus wb and ict antibody detection in chronic pulmonary aspergillosis |
Rozaliyani A., Setianingrum F., Azahra S., Abdullah A., Fatril A.E., Rosianawati H., Burhan E., Handayani D., Arifin A.R., Zaini J., Tugiran M., Adawiyah R., Syam R., Wibowo H., Wahyuningsih R., Kosmidis C., Denning D.W. |
Journal of Fungi |
|
Q1 |
|
|
159 |
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study |
Surendra H., Elyazar I.R., Djaafara B.A., Ekawati L.L., Saraswati K., Adrian V., Widyastuti, Oktavia D., Salama N., Lina R.N., Andrianto A., Lestari K.D., Burhan E., Shankar A.H., Thwaites G., Baird J.K., Hamers R.L. |
The Lancet Regional Health - Western Pacific |
1 |
#N/A |
|
|
225 |
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
A living WHO guideline on drugs to prevent covid-19 |
Lamontagne F., Agoritsas T., Siemieniuk R., Rochwerg B., Bartoszko J., Askie L., MacDonald H., Amin W., Bausch F.J., Burhan E., Cecconi M., Chanda D., Dat V.Q., Du B., Geduld H., Gee P., Nerina H., Hashimi M., Hunt B.J., Kabra S., Kanda S., Kawano-Dourado L., Kim Y.-J., Kissoon N., Kwizera A., Leo Y.-S., Mahaka I., Manai H., Mino G., Nsutebu E., Pshenichnaya N., Qadir N., Ranganathan S.S., Sabzwari S., Sarin R., Sharland M., Shen Y., Souza J.P., Stegemann M., Ugarte S., Venkatapuram S., Vuyiseka D., Preller J., Brignardello-Petersen R., Kum E., Qasim A., Zeraatkar D., Owen A., Guyatt G., Lytvyn L., Diaz J., Vandvik P.O., Jacobs M. |
The BMJ |
10 |
Q1 |
|
|
349 |
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial |
Dilogo I.H., Aditianingsih D., Sugiarto A., Burhan E., Damayanti T., Sitompul P.A., Mariana N., Antarianto R.D., Liem I.K., Kispa T., Mujadid F., Novialdi N., Luviah E., Kurniawati T., Lubis A.M.T., Rahmatika D. |
Stem Cells Translational Medicine |
|
Q1 |
|
|